Research Impact

h-index

N/A

Research impact score

Publications

0

Total publications

Trial Results

0

Published trial results

Citations

0

Total citations

Drug Portfolio

Analytics

Trial Phases

Phase 11
Phase 22
Phase 31

Trial Status

Completed3
Other1

Role Distribution

Principal Investigator4
PI Rate100%

Activity Timeline

Clinical Trials (4)

NCT06369974Phase 1/2Enrolling By Invitation
Single Participant Study of an Experimental ASO Treatment for TUBB4A-related Leukodystrophy
Genetic Disease
PrincipalinvestigatorStart date: 2024-09-18
NCT02851862Completed
A Natural History of Late Onset Tay-Sachs Disease
GM2 Gangliosidosis
PrincipalinvestigatorStart date: 2016-04-01
NCT02851563Completed
A Natural History Study of Canavan Disease
Canavan Disease
Principalinvestigator

Research Network

Collaboration Network

13 collaborators·50 connections
Network Legend
KOL
Current Investigator
CO
High-influence Collaborator
CO
Collaborator
Click: view details
Double-click: go to profile
Drag: move node

Research Areas & Affiliations

Similar Key Opinion Leaders

Discover other key opinion leaders with similar research profiles, therapeutic areas, and collaboration networks.

10 similar investigators found

Jorn-Sven Kuhl, MD

University of Leipzig

Related
1 trials

Shared therapeutic areas:

Cerebral Adrenoleukodystrophy (CALD)

Worked with same sponsors:

Genetix Biotherapeutics Inc.
Collaborated on 1 trial
Similarity Score14%

Jakob Sieker, MD.

bluebird bio, Inc.

Related
1 trials

Shared therapeutic areas:

Cerebral Adrenoleukodystrophy (CALD)

Worked with same sponsors:

Genetix Biotherapeutics Inc.
Collaborated on 1 trial
Similarity Score14%

Patrick Aubourg, MD, PhD

Hôpital Bicêtre

Related
1 trials

Shared therapeutic areas:

Cerebral Adrenoleukodystrophy (CALD)

Worked with same sponsors:

Genetix Biotherapeutics Inc.
Collaborated on 1 trial
Similarity Score14%

David Williams, MD

Boston Children's Hospital

Related
2 trials

Shared therapeutic areas:

Cerebral Adrenoleukodystrophy (CALD)

Worked with same sponsors:

Genetix Biotherapeutics Inc.
Collaborated on 1 trial
Similarity Score14%

Paul Orchard, MD

University of Minnesota

Related
2 trials

Shared therapeutic areas:

Cerebral Adrenoleukodystrophy (CALD)

Worked with same sponsors:

Genetix Biotherapeutics Inc.
Collaborated on 1 trial
Similarity Score14%

Hernan Amartino, MD

Medeos SRL

Related
1 trials

Shared therapeutic areas:

Cerebral Adrenoleukodystrophy (CALD)

Worked with same sponsors:

Genetix Biotherapeutics Inc.
Collaborated on 1 trial
Similarity Score14%

Adrian Thrasher, MD, PhD

Great Ormond Street Hospital for Chidren NHS Foundation Trust

Related
1 trials

Shared therapeutic areas:

Cerebral Adrenoleukodystrophy (CALD)

Worked with same sponsors:

Genetix Biotherapeutics Inc.
Collaborated on 1 trial
Similarity Score14%

Satiro de Oliveira, MD

University of California, Los Angeles

Related
1 trials

Shared therapeutic areas:

Cerebral Adrenoleukodystrophy (CALD)

Worked with same sponsors:

Genetix Biotherapeutics Inc.
Collaborated on 1 trial
Similarity Score14%

Nicholas Smith, MD

Women and Children's Hospital

Related
1 trials

Shared therapeutic areas:

Cerebral Adrenoleukodystrophy (CALD)

Worked with same sponsors:

Genetix Biotherapeutics Inc.
Collaborated on 1 trial
Similarity Score14%

Christine Duncan, MD

Boston Children's Hospital

Related
1 trials

Shared therapeutic areas:

Cerebral Adrenoleukodystrophy (CALD)

Worked with same sponsors:

Genetix Biotherapeutics Inc.
Collaborated on 1 trial
Similarity Score14%

Publications (0)

No publications found for this investigator.

Clinical Trials (4)

Showing 4 of 4 trials

NCT06369974Phase 1/2PrincipalInvestigator

Single Participant Study of an Experimental ASO Treatment for TUBB4A-related Leukodystrophy

Genetic Disease
Enrolling By Invitation
NCT02851862PrincipalInvestigator

A Natural History of Late Onset Tay-Sachs Disease

GM2 Gangliosidosis
Completed
NCT01896102Phase 2/3PrincipalInvestigator

A Study of the Efficacy and Safety of Hematopoietic Stem Cells Transduced With Lenti-D Lentiviral Vector for the Treatment of Cerebral Adrenoleukodystrophy (CALD)

Cerebral Adrenoleukodystrophy (CALD)
Completed
NCT02851563PrincipalInvestigator

A Natural History Study of Canavan Disease

Canavan Disease
Completed

All 4 trials loaded